Proliferative potential in nasopharyngeal carcinoma: correlations with metallothionein expression and tissue zinc levels.

Metallothionein (MT) is a cysteine-rich protein with pleiotropic functions and a high binding affinity for heavy metals. The present study was designed to examine the relationship between MT expression and tissue zinc levels in conjunction with cell proliferation in nasopharyngeal cancer (NPC). Proliferative activity in NPC was quantified by Ki67 immunolabelling and MT expression was determined by immunohistochemistry. Total zinc and subcellular zinc fractions were analysed by flame atomic absorption spectrometry. MT immunostaining was observed in the nuclei of NPC cells, with the percentage MT immunopositivity ranging from 3.0 to 59.7%. Thirteen tumours displayed weak MT staining and the remaining 11 showed moderate to strong immunostaining. There was a significant positive correlation between MT and Ki67 positivity (P = 0.0127). Tissue zinc levels were higher in NPC as compared with benign nasopharyngeal tissues (4.800 +/- 0.4610 versus 2.889 +/- 0.4045 microgram/g dry wt tissue, respectively; P = 0.0122). Nuclear zinc levels in NPC were significantly higher than levels in membrane and cytosolic fractions (mean zinc levels 1.4840 +/- 0.1489, 0.6286 +/- 0.0789 and 0.3014 +/- 0.0250 microgram/mg protein, respectively). A linear relationship was also observed between nuclear zinc levels and MT immunostaining (P = 0.0024) as well as with Ki67 immunopositivity (P = 0.0123). Our results show that MT and zinc are correlated with proliferative activity in NPC, providing further insights into the biology of this enigmatic and aggressive tumour.

[1]  Sunderman Fw The influence of zinc on apoptosis , 1995 .

[2]  P. C. Huang,et al.  National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. , 1993, Cancer research.

[3]  Y. Hishikawa,et al.  Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus , 1999, British Journal of Cancer.

[4]  M. Cherian,et al.  The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. , 1994, Environmental health perspectives.

[5]  A. Schäffer,et al.  Biochemistry of metallothionein. , 1988, Biochemistry.

[6]  C. Tohyama,et al.  Metallothionein in radiation exposure: its induction and protective role. , 1999, Toxicology.

[7]  Gurmit Singh,et al.  Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours , 1999, The Journal of pathology.

[8]  I. Bremner Nutritional and physiologic significance of metallothionein. , 1991, Methods in enzymology.

[9]  H. Sandstead Understanding zinc: recent observations and interpretations. , 1994, The Journal of laboratory and clinical medicine.

[10]  I. Arany,et al.  Combined Epstein-Barr Virus and Human Papillomavirus Infection in Nasopharyngeal Carcinoma , 1995, The Laryngoscope.

[11]  K. Schmid,et al.  Significance of metallothionein overexpression in human tumours , 1997, Histopathology.

[12]  R. Bahnson,et al.  Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserum. , 1994, Toxicology and applied pharmacology.

[13]  Simon C Watkins,et al.  Nucleophilic distribution of metallothionein in human tumor cells. , 1996, Experimental cell research.

[14]  K. Tsujikawa,et al.  Induction and subcellular localization of metallothionein in regenerating rat liver. , 1994, European journal of cell biology.

[15]  D. Carson,et al.  Ca2+/Mg(2+)-dependent endonuclease from human spleen: purification, properties, and role in apoptosis. , 1993, Biochemistry.

[16]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[17]  V. C. Yang,et al.  Acidic fgf and egf are involved in the autocrine growth stimulation of a human nasopharyngeal carcinoma cell line and sub‐line cells , 1993, International journal of cancer.

[18]  A. Jayasurya,et al.  Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma , 2000, British Journal of Cancer.

[19]  Immunohistochemical Detection of Metallothionein and MIB1 in Uterine Cervical Squamous Lesions , 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[20]  J. Chin,et al.  Metallothionein in testicular germ cell tumors and drug resistance: Clinical correlation , 1993, Cancer.

[21]  B. Vallee,et al.  Cell cycle regulation of metallothionein in human colonic cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Nakajima,et al.  Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. , 1996, Oncology.

[23]  K. Chia,et al.  Cervical cancer: trends in incidence and mortality in Singapore 1968 to 1987. , 1992, Annals of the Academy of Medicine, Singapore.

[24]  K. Wüthrich,et al.  Comparison of the NMR solution structure and the x-ray crystal structure of rat metallothionein-2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry. , 1993 .

[26]  G. Doig,et al.  Metallothionein expression in renal cancer. , 1998, Urology.

[27]  Metallothionein expression and zinc levels in invasive ductal breast carcinoma. , 1999, Oncology reports.

[28]  Expression of metallothionein and nuclear size in discrimination of malignancy in mucinous ovarian tumors. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[29]  B. Christensson,et al.  Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. , 1994, European journal of cancer. Part B, Oral oncology.

[30]  A. Eastman,et al.  Zinc inhibits apoptosis upstream of ICE/CED-3 proteases rather than at the level of an endonuclease , 1997, Cell Death and Differentiation.

[31]  J. Brisson,et al.  Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.